Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spinal stimulation without surgery shows promise for spasticity relief

NCT ID NCT03815721

Symptom relief Sponsor: Swiss Paraplegic Research, Nottwil Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device that sends electrical stimulation through the skin to the spinal cord, aiming to reduce muscle spasticity and improve movement in people with incomplete spinal cord injury. Twelve participants received repeated sessions of the stimulation. The goal was to see if the benefits could last beyond the treatment period. The trial was terminated early, so the full results are not available.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous spinal cord stimulation device
What this could lead to
If it works, this could offer a non-invasive, home-based way to reduce muscle spasticity and improve movement for people with spinal cord injury.
What could go wrong
The trial was terminated early with only 12 participants, so results are limited. The effects may not last or work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Jan 2019

Finished

May 2021

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * motor and sensory incomplete spinal cord injury classified as grade C or D on the American Spinal Injury Association Impairment Scale * neurological level of spinal cord injury: third cervical to tenth thoracic segment * chronic condition (≥ 12 months post-spinal cord injury) * preserved segmental and cutaneo-muscular reflexes in the lower limbs * able to be verticalized for 6 minutes (with walking aids) * preserved joint mobility, no musculoskeletal diseases * spasticity (with/without antispasticity medication) * stable antispasmodic medication one month prior to as well as during study participation Exclusion Criteria: * neuromuscular diseases, e.g., amyotrophic lateral sclerosis (ALS), Parkinson's disease, Guillain-Barré syndrome, muscular dystrophy * dermatological issues at the stimulation site * acute urinary tract infection at study entry * active implants (e.g., cardiac pacemaker, drug pump) * passive implants between the ninth thoracic level and the first lumbal level (e.g. metal screws/plates for surgical stabilization of spinal fractures) * malignant diseases * heart insufficiency * potential pregnancy (pregnancy test to be conducted as part of the first evaluation)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spasticity, muscle are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Muscle Spasticity spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spasticity, muscle Spinal cord injuries

Contacts and locations

Locations

  • Swiss Paraplegic Centre

    Nottwil, Canton of Lucerne, 6207, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.